Cystoealstometer (Bladder Monitor Device)-Home Use

Sponsor
University of Iowa (Other)
Overall Status
Recruiting
CT.gov ID
NCT05232253
Collaborator
(none)
30
1
1
47.4
0.6

Study Details

Study Description

Brief Summary

The investigators have developed a novel pressure monitoring device called a 'cystoelastometer' that connects to a drainage end ofastandard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate in measuring bladder pressure compared to the gold standard urodynamics that are performed in the clinic or hospital. This study will assess the patients and care givers ability and experience using the cystoelastometer device in a home setting.

Condition or Disease Intervention/Treatment Phase
  • Device: Cystoelastometer - Urodynamics Testing
N/A

Detailed Description

: For patients with neurogenic bladder, regular monitoring of bladder pressure and capacity is a critical component of maintaining renal and urinary health. This monitoring is currently done by in-office urodynamics testing (UDS). This testing is done intermittently, leaving open the possibility of worsening of bladder function and renal deterioration between testing sessions.

This study utilizes a novel pressure and bladder volume monitoring device which is portable and attaches to the end of a standard urinary catheter and measures the pressure in the device and then assists in the drainage of the bladder and records the bladder volume. The investigators will be investigating if this device can be used by patients or their caregivers in a home setting.

This study will enroll patients with neurogenic bladder that currently perform clean intermittent catheterization on a daily basis as part of their regular care. The patients will be asked to use the device at least twice a day for two weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Measurement of Bladder Pressure With a Novel External Device (Cystoealstometer) - Home
Actual Study Start Date :
Feb 18, 2021
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neurogenic Bladder Patient

Patients with neurogenic bladder

Device: Cystoelastometer - Urodynamics Testing
The non-invasive cystoelastometer device connects to the drainage end of urinary catheter that the patient uses for routine daily catheterization. Once urine flows into the device a pressure measurement is recorded and stored in the device along with the time and date. The remaining urine is then evacuated through the catheter and device and the cystoelastometer records the volume of urine evacuated. The measurement(s) of bladder pressure and volume as well as the time and date can later be transmitted wirelessly to a smart phone that contains an app for the device.

Outcome Measures

Primary Outcome Measures

  1. Home use of bladder pressure and volume monitoring device- Cystoelastometer [Two weeks]

    Utilization study of novel external cystoelastometer device - Home bladder pressure and volume monitor recorded in terms of cm H2O pressure and urine evacuation device with volume measurement in terms of milliliters.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Months to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients seen in the University of Iowa Pediatric Urology Clinic with neurogenic bladder managed with clean intermittent catheterization.

  • Patients who haven't had any change in management

  • Patients who had recently had UDS (urodynamic study) performed

Exclusion Criteria:
  • phone which is not iOS compatible

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Iowa Hospital and Clinics Iowa City Iowa United States 52242

Sponsors and Collaborators

  • University of Iowa

Investigators

  • Principal Investigator: Christopher S Cooper, MD, University of Iowa

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christopher Cooper, Associate Dean, University of Iowa
ClinicalTrials.gov Identifier:
NCT05232253
Other Study ID Numbers:
  • 202010469
First Posted:
Feb 9, 2022
Last Update Posted:
Feb 9, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Christopher Cooper, Associate Dean, University of Iowa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2022